Gray Announces Closing and Upsizing of Revolving Credit Facility Refinancing and Announces Update on Term Loan and BMI Sale Proceeds

Written by Customer Service on February 16, 2024. Posted in Public Companies.

ATLANTA, Feb. 16, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray,” “we,” “us” or “our”) (NYSE: GTN) announced today that it has closed a refinancing and upsizing of its revolving credit facility and has postponed its planned opportunistic refinancing of its $1.19 billion term loan due in 2026, due to recent market conditions. In addition, Gray announced today that, on February 8, 2024, Gray received approximately $110 million in pre-tax cash proceeds from the closing of the previously announced sale of Broadcast Music, Inc. (“BMI”) to a shareholder group led by New Mountain Capital, LLC. On January 30, 2024, Gray launched a process, subject to market and other conditions, to refinance a portion of its existing senior credit facilities. Subsequent developments in the capital markets led Gray to postpone the process through...

Athene Holding Ltd. Declares First Quarter 2024 Preferred Stock Dividends

Written by Customer Service on February 16, 2024. Posted in Dividend Reports And Estimates.

WEST DES MOINES, Iowa, Feb. 16, 2024 (GLOBE NEWSWIRE) — Athene Holding Ltd. (“Athene”) announced that it has declared the following preferred stock dividends on its non-cumulative preferred stock (represented by depositary shares, each representing a 1/1,000th interest in a share of preferred stock), payable on April 1, 2024 to holders of record as of March 15, 2024. Quarterly dividend of $396.875 per share on the company’s 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock, Series A (the “Series A Preferred Stock”); holders of depositary shares will receive $0.396875 per depositary share. Quarterly dividend of $351.5625 per share on the company’s 5.625% Fixed-Rate Perpetual Non-Cumulative Preferred Stock, Series B (the “Series B Preferred Stock”); holders of depositary shares will receive $0.3515625 per depositary...

United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock

Written by Customer Service on February 16, 2024. Posted in Dividend Reports And Estimates.

GREENVILLE, S.C., Feb. 16, 2024 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NASDAQ: UCBI) (“United”), reported that its Board of Directors approved a quarterly cash dividend of $429.6875 per share (equivalent to $0.4296875 per depositary share or 1/1000th interest per share) on the Company’s 6.875% Non-Cumulative Perpetual Preferred Stock, Series I (NASDAQ: UCBIO). The dividend is payable March 15, 2024 to shareholders of record on February 29, 2024. About United Community Banks, Inc.United Community Banks, Inc. (NASDAQ: UCBI) is the financial holding company for United Community, a top 100 US financial institution that is committed to improving the financial health and well-being of its customers and ultimately the communities it serves. United Community provides a full range of banking, wealth management, and mortgage services....

Autoscope Technologies Corporation Announces Dividend

Written by Customer Service on February 16, 2024. Posted in Dividend Reports And Estimates.

MINNEAPOLIS, Feb. 16, 2024 (GLOBE NEWSWIRE) — Autoscope Technologies Corporation (“Autoscope”) (OTCQX: AATC) announced today that its Board of Directors has declared a regular quarterly dividend of $0.13 per share of common stock, payable on March 5, 2024 to shareholders of record at the close of business on February 27, 2024. About Autoscope Technologies Corporation Autoscope Technologies Corporation is a global company dedicated to helping improve safety and efficiency for cities and highways by developing and delivering above-ground detection technology, applications and solutions. We give Intelligent Transportation Systems (ITS) professionals more precise and accurate information – including real-time reaction capabilities and in-depth analytics – to make more confident and proactive decisions. We are headquartered in Minneapolis,...

Euroseas Ltd. Sets Date for the Release of Fourth Quarter 2023 Results, Conference Call and Webcast

Written by Customer Service on February 16, 2024. Posted in Public Companies.

ATHENS, Greece, Feb. 16, 2024 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that it will release its financial results for the fourth quarter ended December 31, 2023, on February 21, 2024 before market opens in New York. On the same day, Wednesday, February 21, 2024 at 9:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In). Please quote “Euroseas” to the operator and/or conference ID 13744700.Click here for additional...

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

Written by Customer Service on February 16, 2024. Posted in Public Companies.

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will host a conference call and live audio webcast to discuss the FDA approval announced earlier today at 4:15 p.m. ET, February 16, 2024. To participate in the conference call Q&A and live audio webcast, please register at https://register.vevent.com/register/BI0633b8a73e8b4c578bfed2a8ef37003e. To listen to the live or archived webcast, please register at https://edge.media-server.com/mmc/p/uqbbcfz4/. The live and archived webcast can be accessed in the Investors section of the Company’s website, IR.Iovance.com. The archived webcast will be available for one year. About Iovance...

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

Written by Customer Service on February 16, 2024. Posted in Public Companies.

AMTAGVI (lifileucel) Product Shot AMTAGVI (lifileucel) product packaging AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after anti-PD-1 and targeted therapy AMTAGVI deploys patient-specific immune cells that recognize and fight cancer SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) cell therapies for patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved AMTAGVI™ (lifileucel) suspension for intravenous infusion. AMTAGVI is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with...

NevGold Announces Closing of Second Tranche of Upsized C$2.35M Non-Brokered Private Placement Financing and Announces Shares-for-Debt Transaction

Written by Customer Service on February 16, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION TO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES Vancouver, British Columbia, Feb. 16, 2024 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce closing of a second and final tranche of a non-brokered private placement financing (see previous News Releases dated December 20, 2023 and January 5, 2024) of 2,656,250 common shares of the Company (the “Common Shares”) issued at a price of C$0.32 per Common Share for gross proceeds of C$850k (the “Offering”). The Company increased the total size of the Private Placement to $2.35 million gross proceeds due to investor interest. A total of 7,343,750 Common Shares were issued under the first and second tranches for $2.35 million gross proceeds. NevGold CEO, Brandon Bonifacio, comments: “It...

Banco Comercial Português, S.A. informs on a notice received from Bank of America Corporation

Written by Customer Service on February 16, 2024. Posted in Public Companies.

Banco Comercial Português, S.A. informs on a notice received from Bank of America Corporation Attachment 2024 02 16 Participação qualificada EN

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

Written by Customer Service on February 16, 2024. Posted in Public Companies.

Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North American 3PL Distribution Partnerships NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc., (NASDAQ: STSS) (NASDAQ: STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new sales and distribution opportunities through the addition of new North American 3PL partnerships to expand its reach into the global healthcare market. These additional third-party logistics partnerships, along with a developing alliance with Roncadelle Operations, a driving force in the development of safe, novel medical drug delivery devices, would combine the strengths and capabilities of the two companies...

Day: February 16, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice